Paclitaxel and docetaxel in the treatment of breast cancer

Author： Saloustros Emmanouel   Mavroudis Dimitris   Georgoulias Vassilis  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.15, 2008-10, pp. : 2603-2616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Economic Evaluation of Docetaxel and Paclitaxel Regimens in Metastatic Breast Cancer in the UK

By Benedict Ágnes  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 847-859

Adis International

Access to resources Recommend Favorite

Recent findings with docetaxel in postoperative treatment for breast cancer

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2903-2906

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D   Sarkar Tarun   Hutcheon Andrew W  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc   Gligorov Joseph  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer

By Lamb H.M.   Wiseman L.R.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite